Patients Beyond distance and stigma: AI's potential to democratise he... Access to healthcare and health information remains vastly unequal, fuelled by factors like wealth, geography, language, and literacy.
Oncology Liver cancer diagnostic gets FDA breakthrough status, with P... Mursla Bio CEO and founder Pierre Arséne discusses the breakthrough designation from the FDA for their blood test to catch liver cancer early.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face